Stereotaxis Inventory 2010-2025 | STXS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$185B
Thermo Fisher Scientific (TMO)	$160.4B
Edwards Lifesciences (EW)	$44.7B
Alcon (ALC)	$42.9B
IDEXX Laboratories (IDXX)	$41.7B
DexCom (DXCM)	$33B
IQVIA Holdings (IQV)	$28.2B
Mettler-Toledo (MTD)	$25.1B
STERIS (STE)	$22.1B
Waters (WAT)	$17.7B
SONOVA HOLDING (SONVY)	$17B
Hologic (HOLX)	$14.3B
Sysmex ADR (SSMXY)	$10.6B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Globus Medical (GMED)	$7.8B
Glaukos (GKOS)	$5.7B
Teleflex (TFX)	$5B
Integer Holdings (ITGR)	$4B
TransMedics (TMDX)	$3.8B
PROCEPT BioRobotics (PRCT)	$3.3B
LivaNova (LIVN)	$2.3B
Nihon Kohden (NHNKY)	$2B
Veracyte (VCYT)	$1.9B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1.1B